Clinical Trials Browser

Phase 2 × Congenital Hyperinsulinism × Injections × Clear all

NCT03053284 2021-05-14

Pasireotide in Hyperinsulinemic Hypoglycemia

Phase 2 Withdrawn

Hyperinsulinism, Insulinoma, Congenital Hyperinsulinism